Medications

VESIcare LS approved for neurogenic detrusor overactivity

VESIcare LS (solifenacin succinate) oral suspension is now approved to treat neurogenic detrusor overactivity (NDO) in children 2 years and older, the U.S. Food and Drug Administration announced Tuesday.

page 1 from 82